Abstract:Introduction Zolpidem is a nonbenzodiazepine, which acts as a sedative- hypnotic that binds to GABA (A) receptors at the same location as benzodiazepines and increases GABA effects in the central nervous system (Kovacic et al. Oxidative medicine and cellular longevity 2009, 2(1), 52–57). Literature shows that behavioral changes including amnesia, hallucinations, and other neurocognitive effects are some of the known side effects (Edinoff et al. Health psychology research 2021, 9(1), 24927). We present a case about Ms. A, a female in her sixties with a history of major depressive disorder with psychotic symptoms who was brought into the hospital by the EMS under police custody after stabbing her granddaughter with a knife. During the evaluation she was dissociating with impaired memory of the circumstances of her presentation. Collateral information about Ms. A revealed that she had no history of being violent, or any history of psychoactive substance use. Ms. A's home psychiatric medications consisted of Sertraline 100mg, Bupropion 150 mg, Zolpidem 5mg. Objectives To better understand the potential risks with prescribing zolpidem in patient with insomnia. Methods In depth literature review about zolpidem. In addition, observation of Ms. A in the emergency with a full medical workup including but not limited to urine drug screen, brain imaging, lumbar puncture, etc. Results Ms.A medical workup was positive for a urinalysis revealing asymptomatic bacteriuria and she was treated empirically with cefdinir. Her medication regimen consisted of Bupropion 150 mg and Sertraline 100m, both daily. Zolpidem was discontinued and changed to Clonazepam 0.5mg for insomnia. She was also started on Olanzapine 5mg in the AM and 10mg in the PM. Her mental status was noted to have improved after discontinuation of Zolpidem. Patient received one dose in the hospital but after two days since discontinuation her mental status improved. Upon literature review previous reports have been published citing cases of patients on Zolpidem physically acting out while sleeping in a parasomnia-like behavior, with no recollection of memories upon awakening. (Inagaki et al. Primary care companion to the Journal of clinical psychiatry 2010, 12(6)). There are case reports of Zolpidem associated homicide (Paradis et al.The primary care companion for CNS disorders 2012, 14(4). Conclusions One limitation of our study is the patient was noted to have a sudden change in behavior with altered mental status which may be attributed to an underlying asymptomatic bacteriuria. It should be noted that this may have been an incidental finding. This does not exclude the possibility of Zolpidem as the primary cause of the change of her altered mental status or further exacerbating the change in her mental status. Though Zolpidem can be therapeutic and safe, we as clinicians have to be aware of the potential side effects of Zolpidem when prescribing medications. Disclosure of Interest None Declared

A Case Report of Psychoactive Drugs Aggravating and Alleviating Meige Syndrome.

Case Report: Chronological Symptom Profile after Cessation of Overdose Zolpidem in a Patient with Comorbid Bipolar Disorder—from Anxiety, Craving, Paresthesia and Influenza-Like Symptoms to Seizures and Hallucinations

Euphoric Effect Induced by Zolpidem: a Case Study of Magnetoencephalography

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Correlation Between Blepharospasm and Psychological Diseases: the Anxiety, Depression and Sleep Disorder Study

Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine

A Presentation of Meige Syndrome With Associated Upper Motor Neuron Symptoms

A Case Report of REM Sleep Behavior Disorder, Behcet's Disease, Sjogren's Syndrome and Cognitive Dysfunction

Recent advance in treatment of Meige syndrome

Successful treatment with clonazepam and pramipexole of a patient with sleep-related eating disorder associated with restless legs syndrome: a case report

Effect of Botulinum Toxin Type A on Non-Motor Symptoms and Quality of Life in Meige Syndrome.

Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment

Risks Associated with Prescribing Zolpidem: A Case Report and Literature Review

Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report

Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia

Zolpidem-related euphoria, addiction and detoxification: A case report and review of the literature

Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam

1221 Multiple Sleep Latency Testing in Patients with Comorbid Psychiatric Conditions: A Case Report

Effects of integrative therapy with Du Meridian moxibustion, ear acupuncture, and alprazolam on cardiac function and neurotransmitter levels in patients with coronary heart disease and insomnia: An observational study

One-day Investigation of Psychotropic Drugs Use for 149 Inpatients in the Psychosomatic Disorder Department

THE DIAGNOSIS AND TREATMENT OF EPILEPSY AND NARCOLEPSY COMORBIDITY